Literature DB >> 16397163

IV tissue plasminogen activator for stroke in the community: what we know and don't know 10 years after FDA approval.

Anthony J Furlan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16397163     DOI： 10.1161/01.STR.0000199853.52386.70

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  2 in total

1.  Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe.

Authors:  Muhammad A Pervez; Gisele Silva; Shihab Masrur; Rebecca A Betensky; Karen L Furie; Renzo Hidalgo; Fabricio Lima; Eric S Rosenthal; Natalia Rost; Anand Viswanathan; Lee H Schwamm
Journal:  Stroke       Date:  2009-11-12       Impact factor: 7.914

2.  Safety and feasibility of NeuroFlo use in eight- to 24-hour ischemic stroke patients.

Authors:  M D Hammer; L Schwamm; S Starkman; P D Schellinger; T Jovin; R Nogueira; W S Burgin; S Sen; H C Diener; T Watson; P Michel; A Shuaib; W Dillon; D S Liebeskind
Journal:  Int J Stroke       Date:  2012-01-20       Impact factor: 5.266
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.